Mimicry of Amyloid Oligomers
淀粉样蛋白寡聚物的模拟
基本信息
- 批准号:9205515
- 负责人:
- 金额:$ 29.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmino AcidsAmyloidAmyloid beta-ProteinAmyloidosisBiologicalBiological ModelsC-terminalChemical ModelsDiseaseGoalsKnowledgeLeadMeasuresMolecularMutationNeurodegenerative DisordersParkinson DiseasePeptidesPharmaceutical PreparationsPhasePrion DiseasesPropertyProteinsResolutionRoentgen RaysStructureTailThermodynamicsabeta oligomeramyloid peptidebeta pleated sheetbiophysical analysisbiophysical propertiescrosslinkcytotoxicitydesignmimicrynovel therapeuticspolypeptideprevent
项目摘要
Project Summary/Abstract: Mimicry of Amyloid Oligomers
Amyloid oligomers now thought to be the damaging molecular species in Alzheimer's disease, Parkinson's
disease, and many other amyloid diseases. Understanding the structures of these oligomers is essential to
understanding their mechanism of action, and quite possibly to developing drugs to prevent or treat these
diseases. Studying the structures of the oligomers at high resolution is challenging, because the oligomers are
heterogeneous and dynamic, forming a variety of sizes and structures that can interconvert. The oligomers are
metastable, with fibrils being the more thermodynamically stable species. Only a few studies have provided
glimpses of amyloid oligomers at atomic resolution. Thus far, the there are no atomic-resolution structures of
oligomers of the beta-amyloid peptide, Abeta, the 40 or 42 amino acid polypeptide closely associated with
Alzheimer's disease.
This proposal aims to determine the structures of oligomers formed by Abeta by incorporating key
fragments of Abeta into macrocyclic beta-sheet peptides designed to mimic the key beta-hairpin building
blocks that are thought to make up Abeta oligomers. The PI has determined X-ray crystallographic structures
at atomic resolution of trimers formed macrocyclic beta-sheet peptides containing fragments from the central
and the C-terminal regions of Abeta. The trimers have a hitherto unprecedented structure consisting of a
triangular arrangement of beta-hairpins that pack together at the three vertices. The trimers further assemble to
form hexamers and dodecamers.
This proposal aims to build on the discovery of these trimers and higher-order oligomeric assemblies. The
broad overarching goal is to understand the relationship between the atomic-resolution structures of the
oligomers and their biological and biophysical properties. To achieve these goals, the PI will synthesize
macrocyclic beta-sheet peptides that incorporate different aspects of Abeta structure, determine the X-ray
crystallographic structures of the oligomers that these peptides form, measure their cytotoxicity, elucidate their
mechanisms of cytotoxcity, and correlate their cytotoxicity and their crystallographic structure by means of
biophysical studies of their solution-phase properties.
项目摘要/摘要:淀粉样蛋白低聚物的模拟
淀粉样蛋白低聚物现在被认为是阿尔茨海默氏症、帕金森氏症
疾病,以及许多其他淀粉样蛋白疾病。了解这些低聚物的结构对于
了解它们的作用机制,并很可能开发药物来预防或治疗这些疾病。
疾病在高分辨率下研究低聚物的结构是具有挑战性的,因为低聚物
异质性和动态性,形成各种尺寸和结构,可以相互转换。述低聚物
亚稳定的,其中原纤维是更稳定的物质。只有少数研究提供了
淀粉样蛋白低聚物的原子分辨率。到目前为止,还没有原子分辨率的结构,
β-淀粉样肽的寡聚体,Abeta,40或42个氨基酸的多肽,与
老年痴呆症
该提案旨在通过结合关键的结构来确定Abeta形成的低聚物的结构。
将Abeta片段转化为大环β折叠肽,设计用于模拟关键的β-发夹结构
被认为构成Abeta寡聚体的嵌段。PI已经确定了X射线晶体结构
在三聚体的原子分辨率下,形成的大环β-折叠肽含有来自中心的片段,
和Abeta的C末端区域。三聚体具有迄今为止前所未有的结构,
在三个顶点处挤在一起的β-发夹的三角形排列。三聚体进一步组装成
形成六聚体和十二聚体。
这项建议旨在建立在这些三聚体和更高阶的低聚组装的发现。的
一个广泛的总体目标是了解原子分辨率结构之间的关系,
低聚物及其生物学和生物物理学性质。为了实现这些目标,PI将
大环β折叠肽,包括不同方面的Abeta结构,确定X射线
这些肽形成的低聚物的晶体结构,测量它们的细胞毒性,阐明它们的
细胞毒性机制,并通过细胞毒性与晶体结构相关
生物物理学研究其溶液相性质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES S NOWICK其他文献
JAMES S NOWICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES S NOWICK', 18)}}的其他基金
Synthesis and Evaluation of aza-Novo29 as an Antibiotic Candidate
候选抗生素 aza-Novo29 的合成与评价
- 批准号:
10527638 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
Synthesis and Evaluation of aza-Novo29 as an Antibiotic Candidate
候选抗生素 aza-Novo29 的合成与评价
- 批准号:
10624354 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
Structural and Biological Characterization of Diverse Oligomers Derived from Abeta
Abeta 衍生的多种低聚物的结构和生物学表征
- 批准号:
10214205 - 财政年份:2021
- 资助金额:
$ 29.14万 - 项目类别:
Synthesis and Studies of a New Family of Antibiotics
新抗生素家族的合成与研究
- 批准号:
9231356 - 财政年份:2016
- 资助金额:
$ 29.14万 - 项目类别:
Synthesis and Studies of a New Family of Antibiotics
新抗生素家族的合成与研究
- 批准号:
9014830 - 财政年份:2016
- 资助金额:
$ 29.14万 - 项目类别:
Chemical Models of Protein beta-Sheet Interactions
蛋白质 β-折叠相互作用的化学模型
- 批准号:
7847773 - 财政年份:2009
- 资助金额:
$ 29.14万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 29.14万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 29.14万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 29.14万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 29.14万 - 项目类别:














{{item.name}}会员




